Interferon-γ expression is an independent prognostic factor in ovarian cancer

This publication has 21 references indexed in Scilit:

• Cancer Statistics, 2004
  CA: A Cancer Journal for Clinicians, 2004
• Epigenetic silencing of multiple interferon pathway genes after cellular immortalization
  Oncogene, 2003
• Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
  New England Journal of Medicine, 2003
• The class II tumour suppressor gene H-REV107-1 is a target of interferon-regulatory factor-1 and is involved in IFNγ-induced cell death in human ovarian carcinoma cells
  Oncogene, 2002
• Phenotypic and Functional Analysis of Tumor-Infiltrating Lymphocytes Compared with Tumor-Associated Lymphocytes from Ascitic Fluid and Peripheral Blood Lymphocytes in Patients with Advanced Ovarian Cancer
  Gynecologic and Obstetric Investigation, 2001
• Interferon-gamma in the first-line therapy of ovarian cancer: a randomized phase III trial
  British Journal of Cancer, 2000
• Clonal Expansion of T Cells That Are Specific for Autologous Ovarian Tumor among Tumor-Infiltrating T Cells in Humans1
  Gynecologic Oncology, 1999
• Cytotoxic response of ovarian cancer cell lines to IFN-γ is associated with sustained induction of IRF-1 and p21 mRNA
  British Journal of Cancer, 1999
• Intraperitoneal recombinant interferon gamma in ovarian cancer patients with residual disease at second-look laparotomy.
  Journal of Clinical Oncology, 1996
• Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide.
  Proceedings of the National Academy of Sciences, 1995